COSTA MESA, CA--(Marketwire - November 03, 2008) - CNS Response, Inc. (OTCBB: CNSO) reported today the results of a study presented at the U.S. Psychiatric and Mental Health Congress by James Greenblatt, M.D., Chief Medical Officer, Walden Behavioral Care Inpatient Psychiatry and Eating Disorder Programs, in Waltham, MA. The poster presentation, titled “EEG Guided Medication Predictions in Treatment Refractory Eating Disorder Patients with Comorbid Depression, Opportunities for Personalized Medicine in Managed Healthcare,” provided an analysis of a four-year cohort study to explore the use of rEEG® to facilitate medication selection for patients with an eating disorder and comorbid depression.
